179 related articles for article (PubMed ID: 17910611)
1. Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.
Acco A; Alves da Silva MH; Batista MR; Yamamoto NS; Bracht A
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):294-300. PubMed ID: 17910611
[TBL] [Abstract][Full Text] [Related]
2. Low doses of tumour necrosis factor alpha and interleukin 1beta diminish hepatic gluconeogenesis from alanine in vivo.
Kelmer-Bracht AM; Broetto-Biazon AC; de Sá-Nakanishi AB; Ishii-Iwamoto EL; Bracht A
Basic Clin Pharmacol Toxicol; 2006 Nov; 99(5):335-9. PubMed ID: 17076683
[TBL] [Abstract][Full Text] [Related]
3. Metabolic fluxes in the liver of rats bearing the Walker-256 tumour: influence of the circulating levels of substrates and fatty acids.
da Veiga RP; da Silva MH; Teodoro GR; Yamamoto NS; Constantin J; Bracht A
Cell Biochem Funct; 2008; 26(1):51-63. PubMed ID: 17265532
[TBL] [Abstract][Full Text] [Related]
4. Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats.
Bykov IL; Palmen M; Rainsford KD; Lindros KO
Inflammopharmacology; 2006 Mar; 14(1-2):36-41. PubMed ID: 16835711
[TBL] [Abstract][Full Text] [Related]
5. Effects of celecoxib and ibuprofen on metabolic disorders induced by Walker-256 tumor in rats.
de Souza CO; Kurauti MA; de Fatima Silva F; de Morais H; Borba-Murad GR; de Andrade FG; de Souza HM
Mol Cell Biochem; 2015 Jan; 399(1-2):237-46. PubMed ID: 25359170
[TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
7. Selective COX2 inhibition improves whole body and muscular insulin resistance in fructose-fed rats.
Hsieh PS; Tsai HC; Kuo CH; Chan JY; Shyu JF; Cheng WT; Liu TT
Eur J Clin Invest; 2008 Nov; 38(11):812-9. PubMed ID: 19021698
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic celecoxib on testicular function in normal and lipopolysaccharide-treated rats.
Winnall WR; Muir JA; Liew S; Hirst JJ; Meachem SJ; Hedger MP
Int J Androl; 2009 Oct; 32(5):542-55. PubMed ID: 18522674
[TBL] [Abstract][Full Text] [Related]
9. Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats.
Moreira CC; Cassolla P; Dornellas AP; de Morais H; de Souza CO; Borba-Murad GR; Bazotte RB; de Souza HM
Int J Exp Pathol; 2013 Feb; 94(1):47-55. PubMed ID: 23317353
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of alanine metabolism in rat liver by ammonia.
Fritz S; Bohnensack R
Biomed Biochim Acta; 1988; 47(12):923-32. PubMed ID: 3254156
[TBL] [Abstract][Full Text] [Related]
11. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
[TBL] [Abstract][Full Text] [Related]
12. Effects of monocrotaline on energy metabolism in the rat liver.
Mingatto FE; Maioli MA; Bracht A; Ishii-Iwamoto EL
Toxicol Lett; 2008 Nov; 182(1-3):115-20. PubMed ID: 18835426
[TBL] [Abstract][Full Text] [Related]
13. The urea cycle and related pathways in the liver of Walker-256 tumor-bearing rats.
Corbello Pereira SR; Darronqui E; Constantin J; da Silva MH; Yamamoto NS; Bracht A
Biochim Biophys Acta; 2004 Apr; 1688(3):187-96. PubMed ID: 15062868
[TBL] [Abstract][Full Text] [Related]
14. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Soni P; Shell B; Cawkwell G; Li C; Ma H
Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
[TBL] [Abstract][Full Text] [Related]
15. Interrelation between the effects of ethanol and thyroid hormones on gluconeogenesis from alanine in perfused rat liver.
Singh SP; Snyder AK
J Lab Clin Med; 1982 May; 99(5):746-53. PubMed ID: 7069271
[TBL] [Abstract][Full Text] [Related]
16. Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver.
Kapoor S; Bahde R
Liver Int; 2009 Aug; 29(7):1125; author reply 1125-6. PubMed ID: 19508621
[No Abstract] [Full Text] [Related]
17. Celecoxib and Ibuprofen Restore the ATP Content and the Gluconeogenesis Activity in the Liver of Walker-256 Tumor-Bearing Rats.
de Souza CO; Kurauti MA; Silva Fde F; de Morais H; Curi R; Hirabara SM; Rosa Neto JC; de Souza HM
Cell Physiol Biochem; 2015; 36(4):1659-69. PubMed ID: 26160389
[TBL] [Abstract][Full Text] [Related]
18. Effect of infliximab on metabolic disorders induced by Walker-256 tumor in rats.
Miksza DR; de Souza CO; de Morais H; da Rocha AF; Borba-Murad GR; Bazotte RB; de Souza HM
Pharmacol Rep; 2013; 65(4):960-9. PubMed ID: 24145090
[TBL] [Abstract][Full Text] [Related]
19. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
20. Effects of sera and spleen cells isolated from partially hepatectomized rats on the growth of Walker-256 tumour.
Ramantanis G; Deliconstantinos G
Biomed Pharmacother; 1985; 39(9-10):482-6. PubMed ID: 3833307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
